Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The comp… Read more
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) - Total Liabilities
Latest total liabilities as of June 2025: $4.43 Million USD
Based on the latest financial reports, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has total liabilities worth $4.43 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Total Liabilities Trend (2023–2025)
This chart illustrates how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Competitors by Total Liabilities
The table below lists competitors of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Martina Berto Tbk
JK:MBTO
|
Indonesia | Rp304.65 Billion |
|
China Ouhua Winery Holdings
KLSE:5188
|
Malaysia | RM3.93 Million |
|
Z.M.H Hammerman Ltd
TA:ZMH
|
Israel | ILA1.25 Billion |
|
Hensel Davest Indonesia Tbk PT
JK:HDIT
|
Indonesia | Rp61.95 Billion |
|
AleAnna, Inc. Warrant
NASDAQ:ANNAW
|
USA | $41.73 Million |
|
INSULET
BE:GOV
|
Germany | €1.91 Billion |
|
Hwa Tai Industries Bhd
KLSE:8478
|
Malaysia | RM73.25 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2025)
The table below shows the annual total liabilities of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $4.43 Million | +0.32% |
| 2024-03-31 | $4.41 Million | +56.43% |
| 2023-03-31 | $2.82 Million | -- |